v3.26.1
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Total revenues $ 11,994 $ 10,855 $ 22,999 $ 21,219  
Selling, general and administrative expenses 2,333 2,140 4,514 4,218  
Research and development expenses 364 352 700 695  
Segment income 2,087 1,834 3,950 3,551  
Restructuring and other costs (98) (82) (147) (180)  
Amortization of acquisition-related intangible assets     (915) (859)  
Interest income     440 501  
Interest expense     (755) (707)  
Other income/(expense)     22 (16)  
Consolidated income before income taxes 1,924 1,709 3,658 3,329  
Segment assets 113,174 101,230 113,174 101,230 $ 110,343
Purchases of property, plant and equipment 450 294 826 656  
Depreciation of property, plant and equipment 331 256 638 532  
Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 2,355 2,115 4,574 4,069  
Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 1,799 1,669 3,466 3,346  
Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 1,188 1,118 2,312 2,248  
Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 6,652 5,953 12,647 11,556  
Segment Reconciling Items          
Segment Reporting [Line Items]          
Total revenues 565 501 1,089 983  
Cost of revenues adjustments (28) (10) (42) (21)  
Selling, general and administrative expenses adjustments (36) (20) (79) (34)  
Restructuring and other costs (98) (82) (147) (180)  
Amortization of acquisition-related intangible assets (485) (429) (915) (859)  
Interest income 207 297 440 501  
Interest expense (401) (404) (755) (707)  
Other income/(expense) 31 (19) 22 (16)  
Segment assets 98,003 87,013 98,003 87,013  
Purchases of property, plant and equipment 90 25 117 61  
Depreciation of property, plant and equipment 0 0 0 0  
Segment Reconciling Items | Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 460 385 877 771  
Segment Reconciling Items | Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 47 58 96 99  
Segment Reconciling Items | Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 17 16 34 34  
Segment Reconciling Items | Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 41 42 82 79  
Operating Segments          
Segment Reporting [Line Items]          
Total revenues 12,559 11,356 24,088 22,202  
Segment income 2,735 2,375 5,133 4,644  
Operating Segments | Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 2,815 2,499 5,450 4,840  
Cost of revenues 1,080 925 2,084 1,781  
Selling, general and administrative expenses 500 467 996 935  
Research and development expenses 140 135 271 274  
Other segment items 54 54 105 98  
Segment income 1,041 919 1,994 1,753  
Restructuring and other costs (13)   (23)    
Segment assets 3,508 3,142 3,508 3,142  
Purchases of property, plant and equipment 59 25 79 69  
Depreciation of property, plant and equipment 69 56 139 114  
Operating Segments | Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 1,847 1,728 3,563 3,446  
Cost of revenues 925 902 1,801 1,737  
Selling, general and administrative expenses 315 317 628 631  
Research and development expenses 140 145 278 282  
Other segment items 43 39 76 71  
Segment income 424 325 779 724  
Restructuring and other costs (17)   (21)    
Segment assets 3,187 3,070 3,187 3,070  
Purchases of property, plant and equipment 17 13 52 57  
Depreciation of property, plant and equipment 27 26 53 50  
Operating Segments | Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 1,205 1,134 2,346 2,282  
Cost of revenues 699 640 1,356 1,319  
Selling, general and administrative expenses 177 183 354 354  
Research and development expenses 45 47 89 92  
Other segment items (50) (42) (99) (93)  
Segment income 334 306 646 610  
Restructuring and other costs (3)   (3)    
Segment assets 1,323 1,295 1,323 1,295  
Purchases of property, plant and equipment 24 25 59 58  
Depreciation of property, plant and equipment 20 23 44 44  
Operating Segments | Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 6,693 5,995 12,729 11,635  
Cost of revenues 5,150 4,667 9,907 9,077  
Selling, general and administrative expenses 677 595 1,274 1,183  
Research and development expenses 27 14 41 27  
Other segment items (97) (106) (208) (209)  
Segment income 936 825 1,714 1,557  
Restructuring and other costs (62)   (95)    
Segment assets 7,152 6,711 7,152 6,711  
Purchases of property, plant and equipment 260 206 518 412  
Depreciation of property, plant and equipment 216 152 402 324  
Elimination of intersegment revenues          
Segment Reporting [Line Items]          
Total revenues $ (565) $ (501) $ (1,089) $ (983)